Published in Mol Brain on September 19, 2016
Somatic coding mutations in human induced pluripotent stem cells. Nature (2011) 9.50
In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol (2001) 9.04
Copy number variation and selection during reprogramming to pluripotency. Nature (2011) 8.24
NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood (2002) 7.78
Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol (2009) 6.39
The development of neural stem cells. Nature (2001) 5.54
Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med (2009) 5.50
Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma (2006) 5.32
Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science (2005) 3.58
Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc Natl Acad Sci U S A (2005) 3.56
Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci U S A (2004) 3.45
Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr Pathol (1990) 2.68
An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells (2013) 2.18
DNA methylation dynamics in human induced pluripotent stem cells over time. PLoS Genet (2011) 2.00
Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease. Exp Neurol (1997) 1.98
Stem cell-derived cardiomyocytes demonstrate arrhythmic potential. Circulation (2002) 1.90
Transplantation of human neural stem cells for spinal cord injury in primates. J Neurosci Res (2005) 1.88
Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. Cancer Res (2010) 1.88
A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci Rep (2014) 1.81
Steps toward safe cell therapy using induced pluripotent stem cells. Circ Res (2013) 1.80
Cell types to order: temporal specification of CNS stem cells. Curr Opin Neurobiol (2009) 1.77
Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity. Stem Cell Rev (2010) 1.77
GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther (2005) 1.72
Toward the development of a global induced pluripotent stem cell library. Cell Stem Cell (2013) 1.70
Human neural stem cells differentiate and promote locomotor recovery in an early chronic spinal cord injury NOD-scid mouse model. PLoS One (2010) 1.66
Molecular imaging of embryonic stem cell misbehavior and suicide gene ablation. Cloning Stem Cells (2007) 1.62
Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. Am J Pathol (1995) 1.49
Capture of neuroepithelial-like stem cells from pluripotent stem cells provides a versatile system for in vitro production of human neurons. PLoS One (2012) 1.46
Genetic and epigenetic stability of human pluripotent stem cells. Nat Rev Genet (2012) 1.38
Evaluation of in vitro proliferative activity of human fetal neural stem/progenitor cells using indirect measurements of viable cells based on cellular metabolic activity. J Neurosci Res (2002) 1.33
Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations. Am J Med Genet (1998) 1.30
Human neural stem/progenitor cells, expanded in long-term neurosphere culture, promote functional recovery after focal ischemia in Mongolian gerbils. J Neurosci Res (2004) 1.30
Tumorigenic development of induced pluripotent stem cells in ischemic mouse brain. Cell Transplant (2010) 1.21
iPS cell technologies: significance and applications to CNS regeneration and disease. Mol Brain (2014) 1.14
Elimination of tumorigenic human pluripotent stem cells by a recombinant lectin-toxin fusion protein. Stem Cell Reports (2015) 1.08
Molecular imaging of stem cells: tracking survival, biodistribution, tumorigenicity, and immunogenicity. Theranostics (2012) 1.08
Long-term safety issues of iPSC-based cell therapy in a spinal cord injury model: oncogenic transformation with epithelial-mesenchymal transition. Stem Cell Reports (2015) 1.02
Injury to the spinal cord niche alters the engraftment dynamics of human neural stem cells. Stem Cell Reports (2014) 0.98
GABAergic interneuron transplants to study development and treat disease. Trends Neurosci (2014) 0.94
γ-secretase inhibitors prevent overgrowth of transplanted neural progenitors derived from human-induced pluripotent stem cells. Stem Cells Dev (2012) 0.92
The function of e-cadherin in stem cell pluripotency and self-renewal. Genes (Basel) (2011) 0.92
Transplantation dose alters the dynamics of human neural stem cell engraftment, proliferation and migration after spinal cord injury. Stem Cell Res (2015) 0.87
Genetic instability of modified stem cells - a first step towards malignant transformation? Am J Stem Cells (2013) 0.84
Stem cells expanded from the human embryonic hindbrain stably retain regional specification and high neurogenic potency. J Neurosci (2013) 0.83
Experimental evidence and early translational steps using bone marrow derived stem cells after human stroke. Front Neurol Neurosci (2013) 0.80
A method for efficiently generating neurospheres from human-induced pluripotent stem cells using microsphere arrays. Neuroreport (2013) 0.80
Mitomycin-treated undifferentiated embryonic stem cells as a safe and effective therapeutic strategy in a mouse model of Parkinson's disease. Front Cell Neurosci (2015) 0.79
Alzheimer's Disease: Mechanism and Approach to Cell Therapy. Int J Mol Sci (2015) 0.79
Histological Characterization of the Tumorigenic "Peri-Necrotic Niche" Harboring Quiescent Stem-Like Tumor Cells in Glioblastoma. PLoS One (2016) 0.79
Teratoma: from spontaneous tumors to the pluripotency/malignancy assay. Wiley Interdiscip Rev Dev Biol (2015) 0.79
Neural induction with a dopaminergic phenotype from human pluripotent stem cells through a feeder-free floating aggregation culture. Methods Mol Biol (2013) 0.78
PSA-NCAM-negative neural crest cells emerging during neural induction of pluripotent stem cells cause mesodermal tumors and unwanted grafts. Stem Cell Reports (2015) 0.77
Models and concepts derived from human teratogenesis and oncogenesis in early life. J Histochem Cytochem (1984) 0.77
Robust production of human neural cells by establishing neuroepithelial-like stem cells from peripheral blood mononuclear cell-derived feeder-free iPSCs under xeno-free conditions. Neurosci Res (2016) 0.76